Faced with the decrease in efficiency of Pfizer compared to the Delta variant, Sputnik offers a reinforcement

After studies conducted by the Center for Disease Control and Prevention (CDC) and the US FDA, they demonstrated a low efficacy of the vaccine developed by the Pfizer laboratory against the Delta variant, the Russian Direct Investment Fund (RIDF) provided back-up with Sputnik Light.